Chandrayaan-4 to launch in 2027- Jitendra Singh announced
India will launch the Chandrayaan-4 mission in 2027 to bring back moon rock samples to Earth, Science and Technology Minister ...
Digi International: Fiscal Q1 Earnings Snapshot
The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for earnings of 50 cents per share. The provider of communication ...
FiercePharma14h
TV drug ad spending reached new heights in January, as Novartis' Pluvicto toppled AbbVie's Skyrizi for top spot
AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting ...
Novartis AG (NVS): Among the Best Foreign Dividend Stocks to Invest In Now
We recently compiled a list of the 10 Best Foreign Stocks With Dividends For Passive Income. In this article, we are going to ...
Moon's two hidden canyons deeper than the Grand Canyon formed at bullet speed by lunar rocks
New research reveals that two massive lunar canyons, deeper than the Grand Canyon, were formed in under 10 minutes by intense ...
PMLiVE20h
Novartis’ Kisqali granted MHRA approval to treat early breast cancer patients
Novartis’ Kisqali (ribociclib) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat a ...
Story of NavIC: crucial indigenous SatNav system, a few hurdles in development path
The partial failure of its NVS-02 navigation satellite on Sunday was the latest in a series of setbacks suffered by the ...
Bar & Bench23h
Delhi High Court bars use of NOVITAS after pharma giant Novartis alleges trademark violation
The Delhi High Court on February 3 passed an interim injunction restraining a pharmaceutical company from using the trademark ...